Lung Cancers Terminated Phase 1 Trials for Docetaxel (DB01248)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00424840Phase I/II Study to Evaluate the Efficacy and Safety of a Combination ChemotherapyTreatment
NCT00356941Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLCTreatment
NCT00511576Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTreatment
NCT00288444Interaction of Docetaxel and Lonafarnib in Patients With Advanced CancerTreatment
NCT00288054S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerTreatment